Ventyx Biosciences, Inc. engages in developing novel small molecule therapeutics for the treatment of autoimmune diseases. Its clinical stage pipeline includes VTX958, a Phase 1 allosteric TYK2 inhibitor for the treatment of a broad range of autoimmune diseases, VTX002, a Phase 2-ready S1P1 receptor modulator for the treatment of ulcerative colitis, and VTX2735, a Phase 1-ready peripheral inhibitor of the NLRP3 inflammasome, which is a mediator of multiple inflammatory conditions. The company was founded by Raju S. Mohan on November 21, 2018 and is headquartered in San Diego, CA.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
82
Frequently Asked Questions
What is Market Cap of Ventyx Biosciences Inc?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Ventyx Biosciences Inc market cap is $221.77M.
What is the 52-week high for Ventyx Biosciences Inc?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Ventyx Biosciences Inc 52 week high is $3.39 as of October 01, 2025.
What is the 52-week low for Ventyx Biosciences Inc?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Ventyx Biosciences Inc 52 week low is $0.783 as of October 01, 2025.
What is Ventyx Biosciences Inc stock price today?
Ventyx Biosciences Inc stock price today is $3.58.
What was Ventyx Biosciences Inc stock price yesterday?
Ventyx Biosciences Inc stock price yesterday was $3.11.
What is the PE ratio of Ventyx Biosciences Inc?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Ventyx Biosciences Inc’s P/E ratio is -1.85.
What is the Price-to-Book ratio of Ventyx Biosciences Inc?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Ventyx Biosciences Inc P/B ratio is 1.0581.
What is the 50-day moving average of Ventyx Biosciences Inc?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Ventyx Biosciences Inc 50-day moving average is $2.66.
How many employess does Ventyx Biosciences Inc has?